Clinical Trial Update: Evaluation of Salbutamol as an Adjuvant Therapy for Pompe Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating salbutamol as adjuvant therapy for Pompe disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pompe Disease

Drugs mentioned

• Salbutamol (salbutamol)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Pompe Disease | Phase 4 | Status: COMPLETED